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Objective: Suboptimal management of Parkinson's disease (PD) medication in hospital may lead to
avoidable complications. We introduced an in-patient PD unit for those admitted urgently with general
medical problems. We explored the effect of the unit on medication management, length of stay and
patient experience.
Methods: We conducted a single-center prospective feasibility study. The unit's core features were
deﬁned following consultation with patients and professionals: specially trained staff, ready availability
of PD drugs, guidelines, and care led by a geriatrician with specialty PD training. Mandatory staff training
comprised four 1 h sessions: PD symptoms; medications; therapy; communication and swallowing. Most
medication was prescribed using an electronic Prescribing and Administration system (iSOFT) which
provided accurate data on time of administration. We compared patient outcomes before and after
introduction of the unit.
Results: The general ward care (n ¼ 20) and the Specialist Parkinson's Unit care (n ¼ 24) groups had
similar baseline characteristics. On the specialist unit: less Parkinson's medication was omitted (13% vs
20%, p < 0.001); of the medication that was given, more was given on time (64% vs 50%, p < 0.001);
median length of stay was shorter (9 days vs 13 days, p ¼ 0.043) and patients' experience of care was
better (p ¼ 0.01).
Discussion: If replicated and generalizable to other hospitals, reductions in length of stay would lead to
signiﬁcant cost savings. The apparent improved outcomes with Parkinson's unit care merit further
investigation. We hope to test the hypothesis that specialized units are cost-effective and improve pa-
tient care using a randomized controlled trial design.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Parkinson's Disease (PD) is the second most common neuro-
degenerative disease in the UK with a prevalence of over 90,000 in
2005 [1]. People with Parkinson's are more likely than their peers
to be admitted to hospital [2] withmore than 80% being emergency
admissions [3]. In the UK, many are admitted to general medical or
elderly care wards with falls, pneumonia, urinary tract infectionor Parkinson's Disease, Royal
. Tel.: þ44 1332 788844.
Ltd. This is an open access article uand reduced mobility [4]. However people with Parkinson's are
often dissatisﬁed with the care provided [5] and, in particular, are
concerned that omitted or delayed administration of medication
may lead to immobility, complications and longer lengths of stay
[5e8]. Staff knowledge of Parkinson's is perceived to be poor [9,10].
The US National Parkinson Foundation (NPF) has called for educa-
tional programmes, recommendations and guidelines for the care
of people with Parkinson's admitted to hospital [11]. Few inter-
vention studies have been published [12]. Early consultation by a
neurologist and promotion of self-medication have also been rec-
ommended [2,13,14].
Emergency care on specialist units by appropriately trained staff
has proved beneﬁcial for a variety of other conditions such asnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Whilst, anecdotally, cohorting of PD in-patients has been tried
before, we are not aware of a published formal assessment of this
approach.
We hypothesized that care on a specialist in-patient Parkinson's
Disease Unit (SPDU) would improve both clinically important and
patient focused outcomes for people with Parkinson's needing ur-
gent medical care. We used staff and patient focus groups to deﬁne
the core features of a specialist Parkinson's unit, which was sub-
sequently initiated as an intervention in the context of a busy acute
elderly medicine ward. This was evaluated using a prospective
study design. Secondary objectives were to explore the feasibility of
planning a multi-center randomized controlled trial, and to eval-
uate and improve the intervention; the staff training program and
SPDU processes.
We choose to investigate a specialist unit rather than train all
hospital staff because low admission rates on many wards could
contribute to decay of staff knowledge.
2. Methods
2.1. Study design
We conducted a single-center prospective pilot study. We compared patient
outcomes before and after the introduction of the specialist Parkinson's unit. For 3
months (AprileJune 2012) we recruited patients with Parkinson's admitted urgently
to general medical/elderly carewards. In July 2012we set up the Specialist in-patient
Parkinson's Disease Unit and trained the staff on the ward chosen to host the
specialist unit. Then (Aug 2012eFeb 2013) we recruited Parkinson's patients going
through this specialist unit. The prospectively determined primary outcomes were
the proportion of PDmedication given on time and length of stay. The study protocol
was approved by the hospital's research and development department and a local
research ethics committee (NRES East Midlands - Northampton, REC reference 11/
EM/0460).
2.2. Setting
The unit was located on an acute 28-bed elderly careward in a 1100 bed teaching
hospital serving a population of 500,000. The number of beds for Parkinson's pa-
tients was ﬂexible, typically 2e6. The specially trained staff cared for other patients
as well as Parkinson's patients. Ward stafﬁng levels were the same as other elderly
care wards in the hospital (see Appendix 1). Most patients were admitted via the
medical assessment unit (MAU) where they typically spent less than 24 h.
2.3. The intervention
The core features of the unit were: mandatory staff training; care led by a
geriatrician with specialist training in Parkinson's; enhanced stock of Parkinson's
drugs (Appendix 2); use of Parkinson's management guidelines; regular multidis-
ciplinary meetings; enhanced access to specialist PD therapists, PD nurse and
movement disorder neurologist; and encouragement of self-medicating when
appropriate. The mandatory education program comprised 4 one-hour training
sessions: PD symptoms and signs; medications, the importance of accurate and
timely drug administration, potential medication side effects; therapy, movement
and handling, cueing strategies and avoidance of dual tasking; communication and
swallowing. Training was in small groups with a trainer. Training videos were
developed by the research team.
2.4. Study population
We included only English-speaking patients with PD who needed urgent
admission to hospital with a medical problem. We used UK brain bank criteria to
conﬁrm the diagnosis of PD [19]. We excluded: patients with parkinsonism due to
conditions other than PD; patients whose acute condition required admission to a
different specialist unit (e.g. Coronary Care Unit, trauma ward). We tried to recruit
consecutive PD admissions. We visited the MAU and elderly care wards daily
(weekdays) to identify eligible patients. When the Parkinson's unit was open, Par-
kinson's patients were sent there if there was a bed available. We sought informed
consent from participants. Initially we allowed a minimum of 24 h to read the pa-
tient information sheet. Following ethical approval this “cooling off” period was
reduced to 4 h (September 2012). We included patients who were confused and
lacked capacity to consent after seeking written advice from a consultee, usually the
next of kin.
2.5. Data collection
On admission we collected baseline demographic and clinical data. The correct
medication schedule was determined by the following hierarchy: report of lucidpatient; report of carer; telephone call to family doctor; drug record from last out-
patient visit. We examined accuracy of prescription and administration. Most
medication was prescribed using an electronic Prescribing and Administration
system (iSOFT) allowing the time of administration to be precisely measured. “On
time” administration was deﬁned as within 30 min of the scheduled time. The
system also recorded reasons medications were omitted. Prescription errors were
checked manually (RS). Potential prescription errors included: medication not
prescribed; wrong dose; wrong dose frequency; wrong preparation; wrong timing
(we allowed 30 min margin of error); prescription of anti-dopaminergic drug. We
counted a single missed dose of Parkinson's medication due to non-prescription of
medication as a prescription error. Changes made to medication schedules by the
treating physician were not considered erroneous if justiﬁed in the medical notes.
On admission and discharge we checked hospital anxiety and depression scale
(HADS), Barthel Index for activities of daily living and Lindop Parkinson's Assess-
ment Scale (LPAS) for mobility [20e22].
A patient experience survey, based on that of Parkinson's UK, was administered
by a researcher who was not part of the clinical team. If the survey had not been
completed by discharge, it was posted out and self-administered. Carers completed
the survey if subjects were unable. In-patient complications were assessed by re-
view of the medical and nursing notes (LB). We used the hospital's patient admin-
istration system and the hospital notes to check mortality at 6 months.
We collected data to assess the feasibility of a future randomized controlled trial.
We evaluated the staff trainingwith staff knowledge questionnaires before and after
each training module and a feedback form after each module.
2.6. Study size
As this was a pilot study, sample size estimations have not been performed.
Using hospital patient administration system (PAS) data, we estimated 40e50
eligible patients would be admitted to relevant wards over a 3-month period. We
estimated a 50% recruitment rate. All the elderly care wards have high bed occu-
pancy so, despite efforts, not all eligible patients would reach the ward hosting the
Parkinson's unit. We estimated 40e50 patients would go through the unit in 7
months and that 20e25 would consent.
2.7. Statistical methods
Statistical analysis was performed using Stata v11. The unit of analysis was the
individual patient for all outcomes except the medication data which were analyzed
based on individual doses. The distribution of continuous outcomes was assessed
using their histograms and results of non-parametric outcomes are presented as
median (interquartile range). The continuous outcomes (age, length of stay, number
of complications, time from drug prescription to administration, frequency of daily
doses, staff knowledge scores), were compared before and after the SPDU using
Mann Whitney U test. All categorical variables (demographics, related to medica-
tion, mortality, discharge, patient satisfaction questions) were compared between
pre and post intervention using Fisher's Exact test. We calculated Spearman's rho to
check for correlation between medication outcomes and length of stay.
3. Results
3.1. Participants
In the general ward care phase of the study we screened 51
patients, 39 were eligible and 20 were recruited: 51% recruitment
rate. In the specialist Parkinson's unit phase we screened 74 pa-
tients, 37 were eligible and 25 were recruited: 67% recruitment rate
(see Fig. 1 for recruitment ﬂowchart). One patient initially recruited
was withdrawn as there was an exclusion criterion. Forty-four
patients were included in the analysis. The proportion of patients
able to sign their own consent formswas: 12 (60%) for general ward
care and 11 (46%) for Parkinson's unit care (p ¼ 0.349.)
3.2. Baseline descriptive data
The general ward care group and the Specialist Parkinson's Unit
care group were well balanced with respect to age, co-morbidity,
usual PD medication (Table 1). Patient presenting complaints
were often non-speciﬁc or multiple but included delirium or psy-
chosis in 25% of each group, and motor problems and falls in 35%
(Parkinson's unit) and 33% (general ward). One patient in each
group was on antipsychotic medication (quetiapine) before
admission and one patient on the Parkinson's unit commenced
quetiapine during the admission.
Fig. 1. Flowchart of patient recruitment to the study.
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On the specialist unit signiﬁcantly less Parkinson's medication
was omitted compared to general ward care (13% vs 20% respec-
tively, p < 0.001, n ¼ 4579 doses); of the Parkinson's medication
that was given, signiﬁcantly more was given on time (64% vs 50%,
p < 0.001, n ¼ 3494 doses). Main medication outcomes are shown
in Table 2. On the Parkinson's unit and general wards respectively ofTable 1
Baseline characteristics of general ward care patients and specialist Parkinson's unit pat
Baseline characteristics
Age e years (median e IQR)
Gender Male
Female
Modiﬁed Hoehn Yahr stage 0e2.5
3
4
5
Charlson co-morbidity index (median IQR)
Disease stage Diagnostic
Maintenance
Complex
Palliative
Usual place of residence Home alone
Home not alone
Residential care
Nursing home
Diagnosis Lower respiratory tract infection/pneumonia
Urinary tract infection
Other infection
Post hypotension
PD related/drug effect
Other
Treatment Patients on L-dopa
Patients on dopamine agonist
L-dopa daily dose (mg) e Median (IQR)
Median number of L-dopa doses per day
Patients using apomorphine infusion therapy
Patients using deep brain stimulation
Results presented as frequency (%), or as otherwise stated.scheduled PD medication 27 doses (1.7%) vs 98 doses (5.2%)
(p < 0.001) were omitted as patients were nil by mouth; 52 (2.4%)
vs 91 (4.9%) (p < 0.001) were omitted as doses had not been pre-
scribed; and 54 (2.5%) vs 34 (1.9%) (p ¼ 0.196) were omitted due to
absent supply.
The number (%) of patients with any prescription errors was 11
(46%) for the Parkinson's unit and 12 (67%) for the general wards
(p ¼ 0.221), (n ¼ 42). The number (%) of doses of PD medicationients.
General ward
care (n ¼ 20)
Specialist Parkinson's
unit care (n ¼ 24)
p value
81 (75e84) 81 (73e84) 0.611
16 (80%) 16 (67%)
4 (20%) 8 (33%) 0.498
0 (0%) 1 (4%)
14 (70%) 9 (38%)
3 (15%) 8 (33%)
3 (15%) 6 (25%) 0.160
1 (0.25e2.75) 1 (0.25e1.75) 0.535
0 0
4 (20%) 1 (4%)
15 (75%) 21 (88%)
1 (5%) 2 (8%) 0.259
6 (30%) 5 (21%)
13 (65%) 13 (54%)
1 (5%) 3 (12%)
0 (0%) 3 (13%) 0.405
5 (25%) 7 (29%)
6 (30%) 7 (29%)
2 (10%) 3 (13%)
2 (10%) 2 (8%)
2 (10%) 4 (17%)
3 (15%) 1 (4%) 0.859
20 (100%) 24 (100%) n/a
7 (35%) 8 (33%) 1.00
450 (363e638) 500 (450e600) 0.223
4 (3e5) 4.5 (3e5) 0.878
0 1 (4%) 1.00
2 (10%) 1 (4%) 0.583
Table 2
Medication outcomes for general ward care patients and specialist Parkinson's unit care.
Medication outcomes General ward care Specialist Parkinson's
unit care
p value
Doses (%) of Parkinsons'
medication given (n ¼ 4579)
Given 1660 (77%) 2080 (86%)
Omitted 437 (20%) 329 (13%)
Not known 72 (3%) 1 (1%) <0.001
Doses (%) of Parkinsons' medication
given early/on timea/late (n ¼ 3494)
Early 147 (10%) 217 (10%)
On time 710 (50%) 1324 (64%)
Late 563 (40%) 533 (26%) <0.001
Doses (%) of L-Dopa medication
given early/on time/late (n ¼ 2382)
Early 101 (10%) 144 (10%)
On time 478 (48%) 917 (66%)
Late 413 (42%) 328 (24%) <0.001
Doses of anti-dopaminergic medication
given (% of all medication) (n ¼ 9906)
32 (1%) 0 <0.001
Main reasons for omission of PD medication
(% of all scheduled PD medication) (n ¼ 4579)
Not prescribed 91 (4.9%) 52 (2.4%) <0.001a
Nil by mouth 98 (5.2%) 27 (1.7%)
Medication not available 34 (1.9%) 54 (2.5%)
Refused by patient 40 (2.2%) 28 (1.3%)
Patient unable to take 30 (1.7%) 49 (2.3%)
Patient off ward 4 (0.2%) 1 (0.05%)
Documented nursing reason 67 (3.6%) 73 (3.4%)
Other reasons 29 (1.4%) 17 (0.7%)
Doses of Parkinson's medication affected by prescription error
(% of all scheduled PD medication) (n ¼ 4579)
171 (7.9%) 64 (2.7%) <0.001
a ‘On time’ administration was deﬁned as within 30 min of the scheduled time. Timeliness analysis was performed on the “given” medication where timed data was
available.
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(2.7%) vs 171 (7.9%) (p < 0.001).
The causes of prescription error were similar in the 2 groups. 29%
of patients had timing errors, and 21% missed at least one dose of
medication as the drug had not been prescribed. Table showing fre-
quenciesof typesofprescriptionerror is availableonline:Appendix3.Table 3
Patient related outcomes for general ward care patients and specialist Parkinson's
unit care.
Patient outcomes General
ward care
Specialist
Parkinson's
unit care
p value
Length of stay in days e median (IQR)
(n ¼ 44)
13 (9e27) 9 (5e16) 0.043
Discharged to usual place of residence
(n ¼ 43)
15 (75%) 17 (74%) 1.000
Unplanned readmission within 30 days
(n ¼ 38)
3 (18%) 6 (26%) 0.707
In-patient mortality (n ¼ 44) 2 (10%) 1 (4%) 0.583
Mortality at 6 months (n ¼ 44) 4 (20%) 3 (13%) 0.684
In-patient complications
New pressure sore, (n ¼ 44) 5 (25%) 2 (8%) 0.217
Falls (n ¼ 44) 7 (35%) 8 (33%) 1.000
Delirium (not present on admission)
(n ¼ 44)
4 (20%) 0 0.036
Constipation (n ¼ 44) 9 (45%) 11 (46%) 0.751
Retention of urine requiring catheter
(n ¼ 44)
4 (20%) 2 (8%) 0.387
Urinary tract infection (n ¼ 44) 3 (15%) 1 (4%) 0.316
Aspiration pneumonia (n ¼ 44) 2 (10%) 1 (4%) 0.583
Any complication (n ¼ 44) 15 (75%) 17 (71%) 0.757
Median (IQR) complications/patient
(n ¼ 44)
1.5 (0.5e3) 1 (0e2) 0.210
Results presented as frequency (%), or as otherwise stated.3.4. Patient related outcomes
Patient related outcomes such as length of stay, mortality and
in-patient complications are shown in Table 3. Median length of
stay was signiﬁcantly shorter on the specialist unit compared to the
general wards (9 days vs 13 days respectively, p¼ 0.043). Therewas
an inverse correlation between length of stay and proportion of
Parkinson's medication given on time (r ¼ 0.3351, p ¼ 0.03) but
we did not ﬁnd a correlation between length of stay and proportion
of Parkinson's medication omitted (r ¼ 0.297, p ¼ 0.056).
The patient experience questionnaire was completed for 31 of
the 41 patients surviving to discharge (76% completion rate). Most
patients (65%) had carer help to complete the questionnaire or their
carers completed it for them. Overall care was rated signiﬁcantly
better on the specialist unit (p ¼ 0.013, see Appendix 4 online for
histogram), Patients' ratings of overall care on the Parkinson's unit
and general wards respectively were: “poor” 0, 0; “fair” 0, 2; “good”
2, 5; “very good” 10, 6; “excellent” 5, 1.
Respondents rated the knowledge of the nursing staff signiﬁ-
cantly more highly on the specialist Parkinson's unit compared to
general ward care (see Appendix 5 online). Also carers rated
communication between staff and family signiﬁcantly more highly
on the specialist Parkinson's unit (p ¼ 0.011).
Sixteen (52%) of respondents reported problems due to missed
medication: 13 (42%) worse off periods, 9 (29%) anxiety, 8 (26%)
prolonged immobility, 5 (16%) pain, and 3 (10%) swallowing prob-
lems. Of the respondents who expressed a view, 14/25 (56%), did
not think it was important for patients to manage their own
medication when in hospital whilst 3 (12%) thought it was very
important to do so.There was no signiﬁcant difference in respondents' perception
of timely medication administration between general ward care
and Parkinson's unit but there was a trend towards perception of
better performance on the Parkinson's unit (see Appendix 6 online
for histogram).3.5. Core features of the specialist Parkinson's unit
We conducted 28 training sessions (mean 7 per module). 22
training sessions were done in July 2012 and six further sessions
took place after July 2012 to capture new staff. Between 52 and 66
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before and after each training module showed signiﬁcant
improvement in staff knowledge (see Appendix 7 online). Each
module received excellent evaluations from staff (median score 7/7
[IQR: 6e7]). Staff self-assessment of ability in relation to key
learning objectives showed improvement for all modules.
3.6. Feasibility outcomes
We explored the feasibility of collecting additional data
regarding mobility, mood and function. Data collection rates on
admission and discharge were: Barthel scale 24 (55%) and 7 (17%),
Hospital Anxiety and Depression Scale 18 (41%) and 8 (20%), Lindop
Parkinson's Gait Assessment 6 (14%) and 2 (5%).
4. Discussion
To our knowledge, this is the ﬁrst acute admission unit for PD
patients that has been designed by staff and patients, initiated in
the context of a busy acute medical hospital and evaluated pro-
spectively, collecting data on clinically important outcomes such as
electronically measured timing of medication, as well as patient
centered outcomes. Our data demonstrate less omitted PD medi-
cation, more PD medication given on time, shorter length of stay,
and better patient experience on a specialist Parkinson's ward.
The strengths of our study design include: involvement of PD
patients and professional staff in the development of the inter-
vention, prospective evaluation of the unit, and electronic data
collection on medication timing. The inclusion of both hospital-
based objective outcomes and patient-centered subjective out-
comes allows different impacts of a complex intervention to be
explored. Limitations of our study include: population not blinded
to hypotheses being tested, non-randomized trial design, small
sample size, Hawthorne effect, and lack of an economic evaluation.
The trial design does not exclude the possibility that other factors
inﬂuenced the observed outcomes. Neither patients nor researchers
were blinded to treatment allocation. Although there was no sig-
niﬁcant difference between groups in time from admission to
recruitment (data not shown), greater efforts on the Parkinson's
specialist unit to recruit patients early, and the shorter cooling off
period prior to consenting, could have inﬂuenced the observed
reduction in length of stay. Although a formal economic evaluation
was not undertaken it appears to be a low cost intervention as no
new staff were appointed and no new beds opened. Pharmacy costs
from wasted drugs held as stock on the ward were negligible. The
main costs related to mandatory staff training (estimate: less than
£5000 or $8000). On the other hand, if the shorter length of stay
were conﬁrmed, and if it could be generalized to other hospitals,
cost savings might be considerable: based on an estimate of 160 PD
admissions a year and an estimated cost per patient per day of £225,
cost savings to our hospital could be in the region of £144,000.
Specialist Parkinson's units have their own limitations. Pressure
on beds in busy acute hospitals means availability of beds on the
specialist Parkinson's unit is not guaranteed. In this study 32 po-
tential participants were excluded because they were sent to other
wards. Similar problems have, however, been overcome by stroke
services. We expect it would be feasible to set up similar units in
hospitals of a similar size in the UK. Where there is no geriatrician
with appropriate expertise the intervention might be adapted to
include daily input from the neurology team.
There is tension between using beds ﬂexibly and potential
improved outcomes in specialized beds; we hope our data will
contribute usefully to the discussion. Increased attention to PD
patients on the ward could have had a negative impact on the other
patients; alternatively care of others could have improved asaspects of the training were relevant to many conditions. Patients
needing care on other specialist units are excluded, so an alterna-
tive approach is needed for these patients. A pro-active Parkinson's
outreach service led by a Parkinson's specialist nurse is a promising
option [8].
We are aware of only one other published study that reports
timeliness of PD medication administration accurately using data
from an electronic drug prescription and administration system;
this US study reported 8% of medication was omitted and 8% was
given late [23]. In a UK-based study of 51 PD patients admitted to
surgical departments, 12% of PD medication was omitted [8]. In an
observational study of 41 PD patients with hip fractures, reported
only in abstract form, a multi-faceted intervention reduced the
amount of omitted PDmedication but did not reduce complications
or length of stay [12]. In all these studies the patient populations
differ to ours.
We believe that the inverse correlation between medication
given on time and length of hospital stay has not been previously
reported using accurately timedmedication data. The association is
in keeping with subjective, retrospective reports of patients
[5,6,10]. We know patients' motor function may deteriorate due to
medication errors [14,24]. It may be that worse motor function
leads to increased length of stay, or timely Parkinson's medication
may be a marker of better overall care. Alternatively the sickest
patients may stay longer and these patients may struggle to take
their medication. The determinants of length of stay in Parkinson's
patients should be researched further.
While our unit administered no contraindicated medication,
others report high rates of prescription (7e40%) and administration
(2e21%) of anti-dopaminergic medications to PD in-patients
[7,8,14,25,26].
Cognitive impairment (indicated by incapacity to sign consent
form) and delirium on admission were common. New onset
delirium after admission was lower on the Parkinson's unit. Man-
agement and prevention of delirium was covered in the training
program. Three of the four new cases of delirium on the general
wards were associated with hospital acquired infection. Multiple
comparisons and small numbers mean this result should be inter-
preted with caution.
The proportion of medication omitted due to lack of stock did
not improve. Although we had enhanced stock, we did not stock all
preparations of all PD drugs. The available stock was not used as
ﬂexibly as we had hoped: e.g. doses of modiﬁed release medica-
tions were omitted rather than a temporary switch to available
standard release drugs.
Following the training program, we found improvements in
both self-reported knowledge and objective knowledge scores
consistent with published reports. Programs that educate nurses
about PD can lead to lasting improvements in knowledge [27] and
have been associated with improved quality of life and functional
outcomes in a residential care setting [28].
In summary we report that, in this pilot study of acutely
admitted PD patients, care on a specialist Parkinson's unit resulted
in less omitted PD medication, more PD medication given on time,
shorter length of stay and better patient experience. The next step
is to conduct a larger randomized controlled trial to try to conﬁrm
the ﬁndings of this pilot study including a health economic evalu-
ation of cost-effectiveness.
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